1800 244 735

Research articles

Click on this link to read our latest research articles.

Click on this link to find out more about Huntington’s NSW ACT Research grant opportunities.

HD Buzz

HDBuzz is a collaboration of scientists who write Huntington’s disease research news in plain language for the global HD community. They have allowed us to retrieve their articles for the NSW ACT Huntington’s community.

Westmead HD Outreach Service

The Outreach Service is part of a multidisciplinary team of medical, nursing and allied health services which provides review, intervention, treatment, case management, counselling, support, education and management of problems and issues associated with Huntington’s for patients, their families and carers. In addition to this care, the service has been involved in local and major international research studies since its establishment at Westmead Hospital in 1995. Hundreds of volunteers have generously participated in research to better understand the disease and in the search for effective treatments.

Westmead Hospital is a HSG Credential Research Site. Professor Clement Loy is the Principal Investigator for this site.

Global research collaboration

The Huntington Study Group (HSG) is the world’s first HD cooperative therapeutic research organization. Today, HSG is a world leader in facilitating high quality clinical research trials and studies that bring us closer to finding more effective treatments for HD and reducing the burden of HD for families affected by the disease.

HSG is an organization of compassionate professionals dedicated to finding treatments that make a difference, providing rigorous care initiatives, and improving the quality of life and outcomes for HD families. They bring together families, medical professionals, clinical researchers, HD advocacy groups, and sponsors to raise awareness of HD, share knowledge and best practices, and develop innovative treatments.

Enroll-HD

Enroll-HD is a clinical research platform and the world’s largest observational study for Huntington’s disease families. It is a resource for the entire HD community, including families, clinicians, researchers, advocates, and anyone else who has a connection to or an interest in HD.

Huntington’s Disease Network of Australia

The Huntington’s Disease Network of Australia (HDNA) is a project conceived by Professor Julie Stout of Monash University. Formed in 2020 to coordinate efforts that enhance care and services for HD and prepare for the advent of new HD treatments. The Map-HD Registry is for people in Australia who are affected by HD. All family members or people affected by HD are encouraged to register, whether or not they are at risk themselves.
 
 

          Huntington's Disease Network of Australia

Exercise increases cellular recycling

Published date: 11 May, 2012

We know that exercise slows down symptom progression in HD mice, but we don’t know why. New research has shown that exercise boosts a cellular recycling process in mouse muscle. These findings could increase our understanding of HD and help develop drugs. Nature and nurture All diseases result from ‘nature and nurture’ – often complex ... Read more

The HDBuzz Prize for young science writers

Published date: 3 May, 2012

We’re pleased to announce the HDBuzz prize, an opportunity for early-career Huntington’s disease researchers to get involved in communicating HD science to the global community, see their work published here and win real human money! HDBuzz 2.0 Eagle-eyed visitors to HDBuzz.net will have noticed that a new logo has appeared atop the growing list of ... Read more

What's the connection between Huntington's Disease and cancer?

Published date: 25 April, 2012

Amongst the general population, cancer is one of the most feared killers. HD families might be forgiven for not thinking much about cancer, given the more obvious clear and present danger. But it turns out that there might be a connection between the mutation that causes HD and the risk of developing cancer, which could ... Read more

Closing the care gap: new guidelines for HD care

Published date: 17 April, 2012

Huntington’s disease may be incurable – but it’s far from untreatable. But the care patients receive from professionals can be inconsistent. Now, a series of recently published internationally-agreed guidelines will help ‘level up’ everyone’s care to the best standards. Mind the gap The Huntington’s Disease Association of England and Wales has as its slogan Hunting ... Read more

Stem-cell neurons make the right connections

Published date: 13 April, 2012

New work suggests that neurons made from stem cells can replace adult neurons better than we thought – at least in mice whose brains have been injured with a toxin. How likely is this to help HD patients – is cell replacement possible in a more chronic condition? HD and the loss of brain cells ... Read more

2012 Therapeutics Conference: a retrospective

Published date: 3 April, 2012

In this special report, we review the 2012 Annual Huntington’s Disease Therapeutics Conference, the year’s biggest gathering of HD drug hunters. We left impressed with a few big themes. The rapid advancement of drugs designed for HD – the emergence of a “systems biology” approach to considering the disease in its entirety – and the ... Read more

Mutant yeast highlights crucial CAG-reading protein

Published date: 14 March, 2012

A study in yeast has highlighted a DNA-reading protein called SPT4 as possibly controlling which CAG-containing genes are active. Since Huntington’s disease is caused by a gene with a long CAG stretch, this might be important for understanding how the HD gene works. CAG and HD The genetic abnormality that causes Huntington’s disease is an ... Read more

HD Therapeutics Conference 2012 Updates: Day 3

Published date: 2 March, 2012

Our third and final daily report from the annual Huntington’s Disease Therapeutics Conference in Palm Springs, California. We will be publishing a summary article and interviews from the conference over the next few weeks. Thursday, March 1, 2012 9:10 – Chris Schmidt works for Pfizer, a pharmaceutical giant working with CHDI to develop new HD ... Read more

HD Therapeutics Conference 2012 Updates: Day 2

Published date: 1 March, 2012

Our second daily report from the annual Huntington’s Disease Therapeutics Conference in Palm Springs, California. The second day’s sessions focused on gene silencing. You can tweet @HDBuzzFeed or email [email protected] with your questions, comments and queries. Wednesday, February 29, 2012 9:03 – HD Therapeutics Conference Update: This morning is focused on gene silencing – a ... Read more

HD Therapeutics Conference 2012 Updates: Day 1

Published date: 29 February, 2012

Our first daily report from the annual Huntington’s Disease Therapeutics Conference in Palm Springs, California. We’ll be bringing you live updates via Twitter over the next two days. You can tweet @HDBuzzFeed or email [email protected] with your questions, comments and queries. Monday, February 27, 2012 17:02 – The Huntington’s Disease Therapeutics Conference has officially begun. ... Read more